Skip to content
Study aid only. Verify against current guidelines before clinical use.
Step 2 CK · Obstetrics & Gynecology

Liver Disease of Pregnancy: Cholestasis & Acute Fatty Liver

One itches, one fails: sorting the liver diseases unique to late pregnancy

Obstetrics & Gynecology·Medical Disorders of Pregnancy·4 min read·9 high-yield points·Reviewed by Veli Bakalov, MD @HemeOncBuddy
Study materialsNo account needed
Card deckActive-recall cards · quick checks · quiz

Intrahepatic cholestasis of pregnancy

Presentation. Intense pruritus, worst on the palms and soles and at night, begins in the late second or third trimester. The skin shows only excoriations, with no primary rash, and jaundice is uncommon. Sex-steroid metabolites overload canalicular bile transport in genetically susceptible women (ABCB4 and ABCB11 variants), so the disorder clusters in families and is more common with twins.

Diagnosis. Pruritus plus serum total bile acids ≥10 µmol/L confirms it; transaminases rise mildly to moderately and bilirubin little. Atypical labs prompt a search for viral hepatitis, gallstones or preeclampsia, and a prolonged PT from fat malabsorption is corrected with vitamin K.

Treatment. Ursodeoxycholic acid (10 to 21 mg/kg/day, commonly 10 to 15) relieves itching and lowers bile acids and transaminases but has not been shown to prevent stillbirth. Antihistamines only aid sleep, and antenatal testing does not reliably predict the sudden fetal deaths.

≥10 µmol/Lserum bile acids: diagnostic with pruritus
≥100 µmol/Lbile acids: stillbirth risk rises sharply; deliver at 36 weeks

Delivery timing. Stillbirth, preterm birth, meconium-stained fluid and neonatal respiratory distress climb with the bile acid level. Bile acids ≥100 µmol/L call for delivery at 36 weeks; lower levels allow delivery between 36 and 39 weeks, depending on the level.

After delivery. Itching fades within days and labs normalize within weeks; persistent abnormalities suggest underlying liver disease such as primary biliary cholangitis or hepatitis C. Cholestasis commonly recurs in later pregnancies and can be provoked by estrogen-containing contraceptives.

Acute fatty liver of pregnancy

Mechanism. Failed mitochondrial fatty acid oxidation causes microvesicular fatty infiltration of hepatocytes. A fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, an autosomal recessive defect, returns toxic long-chain metabolites to its heterozygous mother. Twins, a male fetus and low maternal BMI also raise risk; overall, AFLP complicates about 1 in 7,000–20,000 deliveries.

Presentation. Usually after 30 weeks or just postpartum: malaise, anorexia, nausea, vomiting and epigastric pain, then jaundice and encephalopathy. Polyuria and polydipsia from transient diabetes insipidus (the failing liver clears placental vasopressinase poorly) may come first, and about half of patients have hypertension.

Laboratory signature. Synthetic failure dominates: hypoglycemia, prolonged INR, low fibrinogen and antithrombin, high ammonia and bilirubin, acute kidney injury (rising creatinine and uric acid) and leukocytosis, with only moderately raised transaminases. The diagnosis is clinical, supported by ≥6 of the 14 Swansea criteria without another cause; biopsy showing microvesicular fat is rarely needed and risky with coagulopathy.

  1. Stabilize in intensive careIV dextrose, FFP and cryoprecipitate for coagulopathy, blood pressure control
  2. Deliver promptlyAt any gestational age; induction if progress will be quick, cesarean for usual indications after correcting coagulopathy
  3. Support recoveryAnticipate postpartum hemorrhage; most women recover over weeks, and transplant is rarely needed
  4. Test the newbornScreen for a fatty acid oxidation disorder and offer the parents genetic counseling

An infant with LCHAD deficiency risks hypoketotic hypoglycemia, cardiomyopathy and sudden death; if both parents are carriers, each pregnancy has a 25% chance of an affected fetus.

Distinguishing the mimics

Timing first. Hyperemesis gravidarum causes a mild first-trimester transaminase rise that resolves with rehydration; cholestasis appears in the late second or third trimester; preeclampsia, HELLP and AFLP belong to the third trimester and can present after delivery; viral hepatitis and gallstones occur at any time.

Cholestasis vs acute fatty liver vs HELLP
FeatureIntrahepatic cholestasisAcute fatty liverHELLP syndrome
TimingLate 2nd–3rd trimester3rd trimester or postpartum3rd trimester or postpartum
HallmarkPruritus of palms and soles, no rashVomiting, abdominal pain, jaundice, encephalopathyHypertension, RUQ or epigastric pain
Key labsBile acids ≥10 µmol/L; mild transaminase riseHypoglycemia, ↑INR, ↓fibrinogen, ↑ammonia, AKIHemolysis, ↑LDH, platelets <100,000/μL; normal glucose
Maternal dangerLowLiver failure, hemorrhageHemorrhage, eclampsia, hepatic rupture
ManagementUrsodiol; deliver at 36–39 weeks by bile acid levelStabilize and deliver at any gestationMagnesium, BP control, delivery

HELLP versus AFLP. HELLP brings hemolysis (schistocytes, raised LDH), platelets <100,000/μL and hypertension with normal glucose and usually normal INR and fibrinogen; hypoglycemia, low fibrinogen and high ammonia point to AFLP. The two can overlap, and both are cured by delivery.

Viral hepatitis. Transaminases often exceed 1,000 with positive serology. Hepatitis E, spread fecal-orally in South Asia and Africa, can become fulminant in the third trimester with high maternal mortality. Herpes simplex hepatitis causes fever and very high transaminases, often without skin lesions or much jaundice, and needs empiric IV acyclovir.

Gallstones. Estrogen raises biliary cholesterol and progesterone slows gallbladder emptying, so biliary colic and cholecystitis are common in pregnancy; RUQ pain after meals, fever and a Murphy sign lead to ultrasound, while bile acids and glucose stay normal.